Tunitas raises $10M in series A
BIOCENTURY EXTRA – September, 2015

Tunitas fusion proteins take double aim at allergic disease
BIOWORLD TODAY – January, 2014

Tunitas shops Australian CROs and CMOs for preclinical and Phase I work with fusion protein – CEO
BIOPHARM INSIGHT – June, 2013

Tunitas Therapeutics, Inc: Inhibiting allergic reaction at the cellular level
START-UP – March, 2013

Allergy-fighter Tunitas seeks $2M
SAN FRANCISCO BUSINESS TIMES – January, 2013